JP2009507932A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009507932A5 JP2009507932A5 JP2008537701A JP2008537701A JP2009507932A5 JP 2009507932 A5 JP2009507932 A5 JP 2009507932A5 JP 2008537701 A JP2008537701 A JP 2008537701A JP 2008537701 A JP2008537701 A JP 2008537701A JP 2009507932 A5 JP2009507932 A5 JP 2009507932A5
- Authority
- JP
- Japan
- Prior art keywords
- nsc
- optionally substituted
- compound
- medicament
- alkenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 3
- 241000894006 Bacteria Species 0.000 claims 2
- -1 NSC 130681 Chemical compound 0.000 claims 2
- 229910005965 SO 2 Inorganic materials 0.000 claims 2
- 125000003342 alkenyl group Chemical group 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- 230000001580 bacterial effect Effects 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 150000002431 hydrogen Chemical class 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 231100000572 poisoning Toxicity 0.000 claims 2
- 230000000607 poisoning effect Effects 0.000 claims 2
- 125000000547 substituted alkyl group Chemical group 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- GKQYGRWQCWWSHN-UHFFFAOYSA-N 1,3-bis(4-amino-2-methylquinolin-6-yl)urea;hydron;dichloride Chemical compound Cl.Cl.N1=C(C)C=C(N)C2=CC(NC(=O)NC3=CC4=C(N)C=C(N=C4C=C3)C)=CC=C21 GKQYGRWQCWWSHN-UHFFFAOYSA-N 0.000 claims 1
- IOQMTJOUDKMNPJ-UHFFFAOYSA-N 2-(4-carbamimidoylphenyl)-1-benzofuran-5-carboximidamide;dihydrochloride Chemical compound Cl.Cl.C1=CC(C(=N)N)=CC=C1C1=CC2=CC(C(N)=N)=CC=C2O1 IOQMTJOUDKMNPJ-UHFFFAOYSA-N 0.000 claims 1
- FOBROUGZPKFBBU-UHFFFAOYSA-N 2-(4-carbamimidoylphenyl)-1-benzothiophene-6-carboximidamide;2-hydroxypropanoic acid Chemical compound CC(O)C(O)=O.CC(O)C(O)=O.C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2S1 FOBROUGZPKFBBU-UHFFFAOYSA-N 0.000 claims 1
- DNSRXDNWULQNLB-UHFFFAOYSA-N 2-(4-carbamimidoylphenyl)benzotriazole-5-carboximidamide;dihydrochloride Chemical compound Cl.Cl.C1=CC(C(=N)N)=CC=C1N1N=C2C=C(C(N)=N)C=CC2=N1 DNSRXDNWULQNLB-UHFFFAOYSA-N 0.000 claims 1
- ZZQQXWDSSMQERZ-MDZDMXLPSA-N 2-[2-[(e)-2-(1h-benzimidazol-2-yl)ethenyl]benzimidazol-1-yl]ethanol Chemical compound C1=CC=C2N(CCO)C(\C=C\C=3NC4=CC=CC=C4N=3)=NC2=C1 ZZQQXWDSSMQERZ-MDZDMXLPSA-N 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 1
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims 1
- 125000003282 alkyl amino group Chemical group 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- 150000001412 amines Chemical class 0.000 claims 1
- 125000004104 aryloxy group Chemical group 0.000 claims 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 125000000000 cycloalkoxy group Chemical group 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 125000005553 heteroaryloxy group Chemical group 0.000 claims 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70753105P | 2005-08-12 | 2005-08-12 | |
| US60/707,531 | 2005-08-12 | ||
| US72344205P | 2005-10-05 | 2005-10-05 | |
| US60/723,442 | 2005-10-05 | ||
| PCT/US2006/031550 WO2008041966A2 (en) | 2005-08-12 | 2006-08-11 | Broad spectrum antibacterial compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009507932A JP2009507932A (ja) | 2009-02-26 |
| JP2009507932A5 true JP2009507932A5 (enExample) | 2009-09-17 |
| JP5390186B2 JP5390186B2 (ja) | 2014-01-15 |
Family
ID=39268919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008537701A Expired - Fee Related JP5390186B2 (ja) | 2005-08-12 | 2006-08-11 | 広い抗菌スペクトルを有する抗菌性化合物 |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US7825154B2 (enExample) |
| EP (1) | EP1945209B1 (enExample) |
| JP (1) | JP5390186B2 (enExample) |
| AU (1) | AU2006345003A1 (enExample) |
| CA (1) | CA2617123C (enExample) |
| WO (1) | WO2008041966A2 (enExample) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7825154B2 (en) * | 2005-08-12 | 2010-11-02 | The United States Of America As Represented By The Secretary Of The Army | Small molecule inhibitors of botulinum neurotoxins |
| US7999001B2 (en) * | 2007-01-15 | 2011-08-16 | The United States Of America As Represented By The Secretary Of The Army | Antiviral compounds and methods of using thereof |
| EP2207801B1 (en) * | 2007-10-24 | 2013-04-17 | Functional Genetics, Inc. | Methods of inhibiting viral infection |
| AP2010005308A0 (en) | 2008-01-15 | 2010-06-30 | Siga Technologies Inc | Antiviral drugs for treatment of arenavirus infection |
| GB0821913D0 (en) | 2008-12-02 | 2009-01-07 | Price & Co | Antibacterial compounds |
| WO2011022721A1 (en) * | 2009-08-21 | 2011-02-24 | Microbiotix, Inc | Inhibitors of botulinum neurotoxins |
| US8569346B1 (en) | 2009-10-14 | 2013-10-29 | Biomadison, Inc. | Thiazoline ring compounds as botulinum antagonists |
| US20110152343A1 (en) * | 2009-12-22 | 2011-06-23 | Functional Genetics, Inc. | Protease inhibitors and broad-spectrum antiviral |
| SI2575968T1 (sl) | 2010-06-01 | 2016-06-30 | Summit Therapeutics Plc | Spojine za zdravljenje bolezni, ki je povezana s clostridium difficile |
| WO2011151619A1 (en) | 2010-06-01 | 2011-12-08 | Summit Corporation Plc | Compounds for the treatment of clostridium difficile associated disease |
| WO2011151617A1 (en) | 2010-06-01 | 2011-12-08 | Summit Corporation Plc | Compounds for the treatment of clostridium difficile associated disease |
| WO2011151620A1 (en) | 2010-06-01 | 2011-12-08 | Summit Corporation Plc | Compounds for the treatment of clostridium difficile associated disease |
| WO2011151618A2 (en) | 2010-06-01 | 2011-12-08 | Summit Corporation Plc | Compounds for the treatment of clostridium difficile-associated disease |
| CN103649079B (zh) | 2010-12-22 | 2016-11-16 | Abbvie公司 | 丙型肝炎抑制剂及其用途 |
| WO2012096929A2 (en) | 2011-01-11 | 2012-07-19 | Sunovion Pharmaceuticals Inc. | Heteroaryl compounds and methods of use thereof |
| WO2013052263A2 (en) * | 2011-09-16 | 2013-04-11 | Microbiotix, Inc. | Antifungal compounds |
| WO2013040526A1 (en) * | 2011-09-16 | 2013-03-21 | Microbiotix, Inc. | Antimicrobial compounds |
| US9079935B2 (en) | 2012-08-13 | 2015-07-14 | The Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Vegas | Reducing risk of contracting Clostridium-difficile associated disease |
| JP6223452B2 (ja) * | 2012-09-07 | 2017-11-01 | ノバルティス アーゲー | インドールカルボキサミド誘導体およびその使用 |
| US10724070B2 (en) * | 2012-11-14 | 2020-07-28 | University Of Cincinnati | Modified bacterial pathogens and methods for effectuating rapid response to contamination by known or unknown bacterial pathogens |
| US20180000793A1 (en) | 2015-02-06 | 2018-01-04 | Ernesto Abel-Santos | Inhibiting Germination of Clostridium Perfringens Spores to Reduce Necrotic Enteritis |
| GB201506658D0 (en) | 2015-04-20 | 2015-06-03 | Cellcentric Ltd | Pharmaceutical compounds |
| GB201506660D0 (en) | 2015-04-20 | 2015-06-03 | Cellcentric Ltd | Pharmaceutical compounds |
| CN105287522B (zh) * | 2015-11-25 | 2017-12-15 | 临沂大学 | 双苯并咪唑胺类化合物在制备抗微生物药物中的用途 |
| CN105311020B (zh) * | 2015-11-25 | 2017-12-15 | 临沂大学 | 一种双苯并咪唑胺类化合物及其制备方法 |
| US10526343B2 (en) | 2018-03-26 | 2020-01-07 | University Of Sharjah | Heterocyclic systems and pharmaceutical applications thereof |
| WO2020097400A1 (en) | 2018-11-07 | 2020-05-14 | Dana-Farber Cancer Institute, Inc. | Imidazopyridine derivatives and aza-imidazopyridine derivatives as janus kinase 2 inhibitors and uses thereof |
| US12415816B2 (en) | 2018-11-07 | 2025-09-16 | Dana-Farber Cancer Institute, Inc. | Benzothiazole derivatives and 7-aza-benzothiazole derivatives as janus kinase 2 inhibitors and uses thereof |
| US12522583B2 (en) | 2018-11-07 | 2026-01-13 | Dana-Farber Cancer Institute, Inc. | Benzimidazole derivatives and aza-benzimidazole derivatives as Janus kinase 2 inhibitors and uses thereof |
| MX2022000598A (es) | 2019-07-17 | 2022-03-04 | Summit Oxford Ltd | Preparacion de compuestos antibacterianos. |
| CN114364259B (zh) * | 2019-09-11 | 2025-03-21 | 帝斯曼知识产权资产管理有限公司 | 杀菌用途 |
| CN114401708B (zh) * | 2019-09-11 | 2024-01-23 | 帝斯曼知识产权资产管理有限公司 | 局部组合物 |
| WO2021127367A2 (en) * | 2019-12-19 | 2021-06-24 | The Scripps Research Institute | METHODS FOR INHIBITION OF ALPHA-SYNUCLEIN mRNA USING SMALL MOLECULES |
| IL272003A (en) | 2020-01-13 | 2021-07-29 | The Israel Institute Of Biological Res Iibr | Compounds for use in treatment and/or prevention of clostridial neurotoxins intoxication |
| TW202140477A (zh) | 2020-02-12 | 2021-11-01 | 美商必治妥美雅史谷比公司 | 雜環ｐａｄ４抑制劑 |
| TW202204350A (zh) | 2020-05-06 | 2022-02-01 | 美商雅捷可斯治療公司 | 作為ｊａｋ２抑制劑之６－雜芳基氧基苯并咪唑及氮雜苯并咪唑 |
| WO2022140325A1 (en) * | 2020-12-22 | 2022-06-30 | Gilead Sciences, Inc. | 6-substituted indole compounds |
| US20240059673A1 (en) * | 2020-12-22 | 2024-02-22 | Gilead Sciences, Inc. | Substituted indole compounds |
| US12043632B2 (en) | 2020-12-23 | 2024-07-23 | Ajax Therapeutics, Inc. | 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors |
| GB202100470D0 (en) | 2021-01-14 | 2021-03-03 | Summit Oxford Ltd | Solid tablet dosage for of ridinilazole |
| GB202100471D0 (en) | 2021-01-14 | 2021-03-03 | Summit Oxford Ltd | Preparation of antibacterial compounds |
| EP4323369A1 (en) | 2021-04-16 | 2024-02-21 | Gilead Sciences, Inc. | Thienopyrrole compounds |
| WO2023039159A2 (en) | 2021-09-09 | 2023-03-16 | Abel Santos Ernesto | Inhibitors of c. difficile spore germination |
| JP2024533374A (ja) | 2021-09-10 | 2024-09-12 | ギリアード サイエンシーズ， インコーポレイテッド | チエノピロール化合物 |
| CA3234638A1 (en) | 2021-11-09 | 2023-05-19 | Ajax Therapeutics, Inc. | 6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors |
| WO2023086320A1 (en) | 2021-11-09 | 2023-05-19 | Ajax Therapeutics, Inc. | Forms and compositions of inhibitors of jak2 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996004266A2 (de) | 1994-08-03 | 1996-02-15 | Asta Medica Aktiengesellschaft | Indol-, indazol-, pyridopyrrol- und pyridopyrazol-derivate mit antiasthmatischer, antiallergischer, entzündungshemmender und immunmodulierender wirkung |
| FR2819407B1 (fr) * | 2001-01-18 | 2003-02-21 | Oreal | Compositions antisolaires a base d'un extrait d'au moins une bacterie filamenteuse non photosynthetique et d'au moins un flitre organique insoluble |
| AU2003275225A1 (en) * | 2002-09-20 | 2004-04-08 | Genelabs Technologies, Inc. | Novel aromatic compounds possessing antifungal or antibacterial activity |
| JP2006513162A (ja) * | 2002-11-01 | 2006-04-20 | パラテック ファーマシューティカルズ インコーポレイテッド | 転写因子調節化合物およびその使用方法 |
| US7635685B2 (en) * | 2003-07-03 | 2009-12-22 | Technion Research & Development Foundation Ltd. | Bifunctional antibiotics for targeting rRNA and resistance-causing enzymes and for inhibition of anthrax lethal factor |
| EP1663959A4 (en) | 2003-09-05 | 2007-10-31 | Univ North Carolina | NEW AMIDINE COMPOUNDS FOR THE TREATMENT OF MICROBIAL INFECTIONS |
| WO2005026193A2 (en) * | 2003-09-08 | 2005-03-24 | United States Army Medical Research And Materiel Command | Small molecules and a pharmacophore model for inhibition of botulinum toxin and methods of making and using thereof |
| WO2005109304A2 (en) * | 2003-12-24 | 2005-11-17 | United States Army Medical Research And Materiel Command | Small molecules and a pharmacophore model for inhibition of anthrax lethal factor |
| US7825154B2 (en) * | 2005-08-12 | 2010-11-02 | The United States Of America As Represented By The Secretary Of The Army | Small molecule inhibitors of botulinum neurotoxins |
-
2006
- 2006-08-11 US US11/464,007 patent/US7825154B2/en not_active Expired - Fee Related
- 2006-08-11 CA CA2617123A patent/CA2617123C/en active Active
- 2006-08-11 US US11/464,001 patent/US8691859B2/en not_active Expired - Fee Related
- 2006-08-11 AU AU2006345003A patent/AU2006345003A1/en not_active Abandoned
- 2006-08-11 JP JP2008537701A patent/JP5390186B2/ja not_active Expired - Fee Related
- 2006-08-11 EP EP06851682.2A patent/EP1945209B1/en not_active Not-in-force
- 2006-08-11 WO PCT/US2006/031550 patent/WO2008041966A2/en not_active Ceased
-
2010
- 2010-10-01 US US12/896,338 patent/US20110086877A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009507932A5 (enExample) | ||
| PH12013500381B1 (en) | N-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxamides and use thereof as herbicides | |
| MY142496A (en) | 2,4-diamino-pyrimidines as aurora inhibitors | |
| BR112014010813A2 (pt) | n-(tetrazol-5-il)-aril-carboxamidas e n-(triazol-5-il)-aril-carboxamidas substituídas em 5-fenilo e sua utilização como herbicidas | |
| BR112014002191A2 (pt) | amidas de ácido n-(tetrazol-5-il)- e n-(triazol-5-il)arilcarboxílico e seu uso como herbicidas | |
| TW200617009A (en) | Organic compounds | |
| NO20083207L (no) | Inhibitorer av IAP | |
| MX337527B (es) | Derivado de (aza)indol y su uso para propositos medicos. | |
| MX341732B (es) | Inhibidores de la demetilasa lsd1 basados en arilciclopropilamina y sus usos médicos. | |
| EA200971093A1 (ru) | Терапевтические композиции и их применение | |
| EA201000050A1 (ru) | Замещенные бициклолактамные соединения | |
| JP2012508252A5 (enExample) | ||
| MY151986A (en) | Adamantyl diamide derivatives and uses of same | |
| EA200971096A1 (ru) | Терапевтические композиции и их применение | |
| MX2012000441A (es) | Derivados de 1,2,4-tiazolidin-3-ona y uso en el tratamiento del cancer. | |
| JP2011512324A5 (enExample) | ||
| EA201270275A1 (ru) | Кристаллическое соединение пиридазина | |
| JP2013533253A5 (enExample) | ||
| NO20076145L (no) | Ureadeviater, fremgangsmater for deres fremstilling og anvendelse derav | |
| WO2009141170A3 (en) | Compounds suited as nanocarriers for active agents and their use | |
| JP2014511366A5 (enExample) | ||
| WO2010012745A3 (en) | Benzimidazoles | |
| JP2012511558A5 (enExample) | ||
| MX2010009837A (es) | Tiazolil-dihidro-indazoles. | |
| WO2008110690A3 (fr) | Nouveaux derives indoliques, leurs procedes de preparation et leurs utilisations notamment en tant qu'antibacteriens |